![European Crohn´s and Colitis Organisation - ECCO - OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial European Crohn´s and Colitis Organisation - ECCO - OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000739400/Images/3671_jan_ecco_abstract_predict202103101921483159.jpg)
European Crohn´s and Colitis Organisation - ECCO - OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial
Call for ECCO Educational Workshop 2023 Destinations The primary goal of the Educational Workshops organised by the ECCO Educati
![PDF] Comparison of Clinical Guidelines for Ulcerative Colitis: ECCO, BSG, US and Japanese Guidelines with Reference to Surveillance | Semantic Scholar PDF] Comparison of Clinical Guidelines for Ulcerative Colitis: ECCO, BSG, US and Japanese Guidelines with Reference to Surveillance | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fbf06deaa4f4dd6ac31dbcbd1bcd2f8fe5e271f1/4-Table1-3-1.png)